Patents by Inventor Jürgen Bongs

Jürgen Bongs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6852513
    Abstract: The invention relates to a method for catalysing complex reactions or large molecules, more specifically, to enzyme-catalysed reactions during which undesirable consecutive or subsidiary reactions usually occur; using enzymes which are bonded to a polymer support. According to the invention, undesirable consecutive or subsidiary reactions are to a large extent avoided by selecting a non-porous or almost non-porous support material. In particular, the invention relates to a method for the enzymatic extraction of biomolecules, preferably peptides, proteins, oligosaccharides or polysaccharides from their biologically inactive precursors using enzymes which are bonded to a polymer support, especially a method for extracting insulins or their analogs from the corresponding precursors using enzymes which are bonded to a polymer support.
    Type: Grant
    Filed: May 3, 1999
    Date of Patent: February 8, 2005
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Jürgen Bongs, Johannes Meiwes
  • Patent number: 6649369
    Abstract: The present invention relates to a process for delaying the deactivation of glutaryl amidase during enzyme catalysis. The enzyme catalyst is, after maximum conversion of the substrate, separated off by filtration and can be reused in a subsequent reaction batch. In each reaction cycle, the enzyme catalyst loses activity. The inactivation of the enzyme catalyst can be delayed by bringing it into contact with a thiol during the reaction.
    Type: Grant
    Filed: April 9, 2002
    Date of Patent: November 18, 2003
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Jürgen Bongs, Johannes Meiwes, Wolfgang Kruse, Klaus-Peter Koller
  • Patent number: 6395507
    Abstract: A process is provided for delaying the deactivation of glutaryl amidase during catalysis. The amidase is, after maximum conversion of a substrate, separated off by filtration and can be reused in a subsequent reaction batch. In each reaction cycle, the amidase loses activity. The inactivation of the amidase can be delayed by bringing it into contact with a thiol during the reaction. The thiol is preferably 2-mercaptoethanol or cysteine.
    Type: Grant
    Filed: May 26, 2000
    Date of Patent: May 28, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Jürgen Bongs, Johannes Meiwes, Wolfgang Kruse, Klaus-Peter Koller